New Cases: 588,258 (⬆︎ .43%)
New Deaths: 8,803 (⬆︎ .30%)
USA
New Cases: 56,522 (⬆︎ .18%)
New Deaths: 460 (⬆︎ .08%)
Vaccination Scorecard
Total Vaccinations: 120.8 million (⬆︎ 1.34%)
Total Eligible Population: 45.2%
Total Population: 36.4%
It's to be taken seriously and we want to be sure there are as many safeguards in place as possible while still being able to deliver the necessary services to people.
So now, lemma just say - fuck the anti-vaxxers and the whiny-butt vaccine-reluctant pussies who're are sure to go swarming across the intertoobz to make another mess because of this, and to delay the efforts to get this fucking monster under control.
FDA, CDC call for pause in use of Johnson & Johnson vaccine after six reported cases of rare blood clots
Federal health officials on Tuesday called for a pause in the use of the Johnson & Johnson coronavirus vaccine, saying they are reviewing reports of six U.S. cases of a rare and severe type of blood clot in people after receiving the vaccine.
All six cases occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination, according to a statement issued by the Food and Drug Administration and the Centers for Disease Control and Prevention.
The CDC will hold a meeting Wednesday of its Advisory Committee on Immunization Practices to review the cases and assess their potential significance, the statement said. The FDA will continue to investigate the cases.
“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” the statement said. “This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot.”
The type of clot, called cerebral venous sinus thrombosis, was seen in combination with low levels of blood platelets, the agencies said. Treatment is different from what might typically be administered; while usually an anticoagulant called heparin is used to treat blood clots, it is dangerous to give heparin in this situation. Alternative treatments need to be given, they said.
The officials said the clots “appear to be extremely rare.” They said people who have received the Johnson & Johnson vaccine who develop severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination should contact their doctor.
The rare blood clots, paired with low levels of platelets, were first detected in people in Europe who had received the vaccine developed by AstraZeneca and the University of Oxford. European regulators said it was “plausible” that the clots were linked to that vaccination and have also been reviewing four similar clotting cases after vaccination with the Johnson & Johnson vaccine, which uses a similar technology.
In a statement, Johnson & Johnson spokesman Jake Sargent said the company shares all adverse event reports about individuals who receive the vaccine with health authorities.
“At present, no clear causal relationship has been established between these rare events and the Janssen COVID-19 vaccine,” Sargent said. “We continue to work closely with experts and regulators to assess the data and support the open communication of this information to healthcare professionals and the public.”
No comments:
Post a Comment